Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SALTZ, Leonard B")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 44

  • Page / 2
Export

Selection :

  • and

The camptothecinsPIZZOLATO, Joseph F; SALTZ, Leonard B.Lancet (British edition). 2003, Vol 361, Num 9376, pp 2235-2242, issn 0140-6736, 8 p.Article

Phase I Study of Two Schedules of Oral S-1 in Combination with Fixed Doses of Oxaliplatin and Bevacizumab in Patients with Advanced Solid TumorsCHUNG, Ki Y; SAITO, Kaku; ZERGEBEL, Christopher et al.Oncology. 2011, Vol 81, Num 2, pp 65-72, issn 0030-2414, 8 p.Article

Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup TrialSHUJI OGINO; XIAOYUN LIAO; HANTEL, Alexander et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 23, pp 1789-1798, issn 0027-8874, 10 p.Article

Nonoperative Management of Rectal Cancer With Complete Clinical Response After Neoadjuvant TherapySMITH, James D; RUBY, Jeannine A; GOODMAN, Karyn A et al.Annals of surgery. 2012, Vol 256, Num 6, pp 965-970, issn 0003-4932, 6 p.Article

Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma: A Randomized TrialABOU-ALFA, Ghassan K; JOHNSON, Philip; KNOX, Jennifer J et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 19, pp 2154-2160, issn 0098-7484, 7 p.Article

KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803OGINO, Shuji; MEYERHARDT, Jeffrey A; BENSON, Al B et al.Clinical cancer research (Print). 2009, Vol 15, Num 23, pp 7322-7329, issn 1078-0432, 8 p.Article

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudySALTZ, Leonard B; CLARKE, Stephen; COUTURE, Felix et al.Journal of clinical oncology. 2008, Vol 26, Num 12, pp 2013-2019, issn 0732-183X, 7 p.Article

Potential Regional Differences for the Tolerability Profiles of FluoropyrimidinesHOLLER, Daniel G; CASSIDY, Jim; BERTINO, Joseph R et al.Journal of clinical oncology. 2008, Vol 26, Num 13, pp 2118-2123, issn 0732-183X, 6 p.Article

Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer : Results of CALGB 89803SALTZ, Leonard B; NIEDZWIECKI, Donna; HOLLIS, Donna et al.Journal of clinical oncology. 2007, Vol 25, Num 23, pp 3456-3461, issn 0732-183X, 6 p.Article

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients. CommentaryHIOTIS, Spiros P; WEBER, Sharon M; COHEN, Alfred M et al.Journal of the American College of Surgeons. 2002, Vol 194, Num 2, pp 131-136, issn 1072-7515Article

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Authors' replyERLICHMAN, Charles; GOLDBERG, Richard M; MILLER, Langdon L et al.The New England journal of medicine. 2001, Vol 344, Num 4, pp 305-307, issn 0028-4793Article

BRAF Mutation Predicts for Poor Outcomes After Metastasectomy in Patients With Metastatic Colorectal CancerYAEGER, Rona; CERCEK, Andrea; SOLIT, David B et al.Cancer. 2014, Vol 120, Num 15, pp 2316-2324, issn 0008-543X, 9 p.Article

Unusual DNA mismatch repair―deficient tumors in Lynch syndrome: a report of new cases and review of the literatureKARAMURZIN, Yevgeniy; ZHAOSHI ZENG; PATY, Philip B et al.Human pathology. 2012, Vol 43, Num 10, pp 1677-1687, issn 0046-8177, 11 p.Article

Phase II Study of the Anti-Cytotoxic T-Lymphocyte― Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal CancerCHUNG, Ki Y; GORE, Ira; SALTZ, Leonard B et al.Journal of clinical oncology. 2010, Vol 28, Num 21, pp 3485-3490, issn 0732-183X, 6 p.Article

Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal CancerREIDY, Diane Lauren; VAKIANI, Efsevia; DONTABHAKTUNI, Aruna et al.Journal of clinical oncology. 2010, Vol 28, Num 27, pp 4240-4246, issn 0732-183X, 7 p.Article

P27 Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803BERTAGNOLLI, Monica M; WARREN, Robert S; GOLDBERG, Richard M et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2116-2122, issn 1078-0432, 7 p.Article

Association of Family History With Cancer Recurrence and Survival Among Patients With Stage III Colon Cancer. CommentaryCHAN, Jennifer A; MEYERHARDT, Jeffrey A; GOLDBERG, Richard M et al.JAMA, the journal of the American Medical Association. 2008, Vol 299, Num 21, issn 0098-7484, 1515-1523, 1564-1565 [11 p.]Article

Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer : Findings From Cancer and Leukemia Group B 89803MEYERHARDT, Jeffrey A; NIEDZWIECKI, Donna; HOLLIS, Donna et al.Journal of clinical oncology. 2008, Vol 26, Num 25, pp 4109-4115, issn 0732-183X, 7 p.Article

Pathologic Stage Is Most Prognostic of Disease-free Survival in Locally Advanced Rectal Cancer Patients After Preoperative ChemoradiationQUAH, Hak-Mien; CHOU, Joanne F; GONEN, Mithat et al.Cancer. 2008, Vol 113, Num 1, pp 57-64, issn 0008-543X, 8 p.Article

Bevacizumab 5 mg/kg can be infused safely over 10 minutesREIDY, Diane L; CHUNG, Ki Y; TIMONEY, John P et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2691-2695, issn 0732-183X, 5 p.Article

FDG-PET Assessment of Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Is Not Associated With Long-Term Prognosis: A Prospective EvaluationRUBY, Jeannine A; LEIBOLD, Tobias; AKHURST, Timothy J et al.Diseases of the colon & rectum. 2012, Vol 55, Num 4, pp 378-386, issn 0012-3706, 9 p.Article

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803OGINO, Shuji; SHIMA, Kaori; HANTEL, Alexander et al.Clinical cancer research (Print). 2012, Vol 18, Num 3, pp 890-900, issn 1078-0432, 11 p.Article

Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803NG, Kimmie; OGINO, Shuji; SCHAEFER, Paul L et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 20, pp 1540-1551, issn 0027-8874, 12 p.Article

Impact of Smoking on Patients With Stage III Colon Cancer: Results From Cancer and Leukemia Group B 89803MCCLEARY, Nadine Jackson; NIEDZWIECKI, Donna; HOLLIS, Donna et al.Cancer. 2010, Vol 116, Num 4, pp 957-966, issn 0008-543X, 10 p.Article

Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial TreatmentPOULTSIDES, George A; SERVAIS, Elliot L; SALTZ, Leonard B et al.Journal of clinical oncology. 2009, Vol 27, Num 20, pp 3379-3384, issn 0732-183X, 6 p.Article

  • Page / 2